Lifeboat Foundation

Speculation on 3D printed tissue coming to humans sooner than we think is backed by new pre-clinical findings from 3D bioprinting company Organovo (NASDAQ: ONVO). Though it will still be 3 – 5 years before the U.S. based Organovo apply for clearance of their liver tissue, that is still sooner than perhaps even the FDA had in mind.

Pre-clinical trial data shows that 3D bioprinted liver tissue has been successfully planted into lab-bred mice. The human liver-cell tissue shows regular functionality and, at this stage, is being explored as a suitable patch for the organ.

A device was just invented by researchers, which can make out up to 17 different diseases just by analyzing the chemical makeup of a persons breath.

This is the worlds first singular device that can make an authenticated reading of a persons breath and the first to accurately check for a wide array of afflictions with just the one sample already mentioned including but not limited to Parkinsons disease and kidney cancer even.

The team of researchers led by Hossam Haick from the Technion-Israel Institute of technology told foreign media, “Since antiquity (~400 BC), physicians learned to evaluate their patients by exhaled volatile organic compounds (VOCs), among other means, that are linked to diseases. For example, the stools and urine of infant noblemen were smelt daily by their physicians.”

Continue reading “Israel invents breath-checking device for identifying diseases” »

3D for the weekend inventors for a great cause to boot.

The British duo 3D printing prosthetic arms for children, for free, in the back garden.

Excellent read on the brain’s inhibitory circuits v. excitatory circuits when involving the processing of smells.

Summary: Inhibitory neurons form neural networks that become broader as they mature, a new study reports.

Source: Baylor College of Medicine.

Continue reading “New Mechanism of How Brain Networks Form Identified” »

The body electrician.

Caloric restriction can help tumour supression.

Tumor suppressors stop healthy cells from becoming cancerous. Researchers from Charité — Universitätsmedizin Berlin, the Medical University of Graz and the German Institute of Human Nutrition in Potsdam-Rehbruecke have found that p53, one of the most important tumor suppressors, accumulates in liver after food withdrawal. They also show that p53 in liver plays a crucial role in the body’s metabolic adaptation to starvation. These findings may provide the foundation for the development of new treatment options for patients with metabolic or oncologic disorders. Results of this study have been published in The FASEB Journal.

Previously described as the ‘guardian of the genome’ and voted ‘Molecule of the Year’ in 1993, p53 is one of the most important proteins regulating cell growth and a major focus for oncology research. It is a protein that has the ability to interrupt the cell cycle and block the division of diseased cells. In order to better understand its physiological regulation, the researchers around Prof. Dr. Michael Schupp from Charité’s Institute of Pharmacology studied the regulation and function of p53 in normal, healthy cells. After withholding food from mice for several hours, the researchers were able to show that p53 protein accumulates in the liver. In order to determine which type of liver cells cause this accumulation, the researchers repeated the experiment using cultured hepatocytes. They found that the starvation-induced accumulation of p53 was indeed detectable in hepatocytes, irrespective of whether these cells were of mouse or human origin.

Continue reading “Food withdrawal results in stabilization of important tumor suppressor” »

Scientists are hailing a pioneering stem cell technique that promises “off-the-shelf” treatment for people with damaged muscles without the existing risks.

Researchers have for the first time successfully implanted “synthetic” cardiac stem cells which successfully repaired muscle tissue that had been weakened by a heart attack.

Traditional stem cell therapy comes with a risk of cancer because scientists are unable to stop the cells replicating and forming tumours.

Continue reading “Synthetic stem cells promise muscle regeneration without cancer risk” »

Time to work off that Chritmas Turkey bigsmile

Making muscles burn more fat and less glucose can increase exercise endurance, but could simultaneously cause diabetes, says a team of scientists from Baylor College of Medicine and other institutions.

Mouse muscles use glucose (carbohydrate) as fuel when the animals are awake and active and switch to fat (lipid) when they are asleep. The team discovered that disrupting this natural cycle may lead to diabetes but, surprisingly, can also enhance exercise endurance. The switch is controlled by a molecule called histone deacetylase 3, or HDAC3. This finding opens the possibility of selecting the right time to exercise for losing body fat but also raises the concern of using HDAC inhibitors as doping drugs for endurance exercise. The study appears in Nature Medicine.

Continue reading “Losing body fat could be facilitated” »

The year 2016 presented the world with a number of big surprises. Some positive, some negative, depending on whom one asks. Here at Medgadget, 2016 will be remembered for many amazing and pleasantly unexpected medical technology developments, many of which are foreshadowing cures for spinal cord injuries, effective treatment of diabetes, new ways to fight heart disease, and many other long sought-after medical solutions. Virtual and augmented reality systems, new imaging techniques, and innovative delivery approaches are changing the way doctors learn and take care of patients.

Looking back on the past year, we selected what we felt to be the most important, innovative, and surprising medical technology developments. They naturally fell into a few categories. Here we share with you Medgadget’s choices of Best Medical Technologies of 2016.